Home
Patented Medicine Prices Review Board

Patented Medicine Prices... Market Share Analysis for March 2026

The Patented Medicine Prices Review Board is a federal quasi-judicial regulatory and reporting agency in Canada with a mandate to protect consumers by ensuring that the prices of patented medication charged by manufacturers of patented drugs are not excessive.

Health > Pharmacy

Domainpmprb-cepmb.gc.ca

Year Founded--

Employees51 - 200

Annual Revenue--

Patented Medicine Prices Review Board

Patented Medicine Prices Review Board (including company regionals)

pmprb-cepmb.gc.ca

See more website traffic and engagement information

Total visits to Patented Medicine Prices Review Board's top domains

Understand Patented Medicine Prices Review Board market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

pmprb-cepmb.gc.ca5.7K

See more with Sales Intelligence

Avg. visit duration in Patented Medicine Prices Review Board's top domains

Analyze Patented Medicine Prices Review Board engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

pmprb-cepmb.gc.ca00:00:25

See more with Sales Intelligence

Avg. pageviews on Patented Medicine Prices Review Board's top domains

See how Patented Medicine Prices Review Board keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

pmprb-cepmb.gc.ca1.63

See more with Sales Intelligence

Patented Medicine Prices Review Board top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Patented Medicine Prices Review Board

These are the website technologies, by industry, used by Patented Medicine Prices Review Board top domains

Mobile (2)

Meta Viewport

Payment & Currencies (2)

Visa

Audio Video Media (1)

YouTube

Conversion & Analytics (1)

Google Analytics

More Technologies

3

See all

News & Signals from Patented Medicine Prices Review Board

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsPatented Medicine Prices Review Board launched Discussion Guide on Apr 15th '24.The next phase of the PMPRB's consultation will begin in summer 2024 with the release of a Discussion Guide.

NewsPatented Medicine Prices Review Board launched Scoping Paper for the Consultations on the Board's Guidelines on Nov 10th '23.On November 10, 2023, the PMPRB published its Scoping Paper for the Consultations on the Board's Guidelines.

NewsPatented Medicine Prices Review Board launches Meds Pipeline Monitor 2022 report.The Patented Medicine Prices Review Board (PMPRB) recently published its Meds Pipeline Monitor 2022 report, which highlights medicines in the pipeline that may impact future clinical practice and drug spending in Canada if approved for sale.